Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Market Update

Julia Lee
June 21, 2018

Equity Investor 18 June

Julia Lee
June 19, 2018

Market Update

Julia Lee
June 7, 2018

Market Update

Julia Lee
June 6, 2018

Equity Investor

Julia Lee
June 5, 2018

Equity Investor 28 May

Julia Lee
May 29, 2018

The SMSF trust deed – video

Bell Direct
May 28, 2018

Setting up your SMSF – video

Bell Direct
May 28, 2018

Equity Investor 21 May

Julia Lee
May 22, 2018